BLRX

BioLineRX

28 hedge funds and large institutions have $1.36M invested in BioLineRX in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$49K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$29K
2 +$20K
3 +$18.9K
4
GWM
Geneos Wealth Management
Colorado
+$10.8K
5
Citigroup
Citigroup
New York
+$4K

Top Sellers

1 -$96K
2 -$60K
3 -$27.9K
4
Morgan Stanley
Morgan Stanley
New York
-$24.7K
5
LPL Financial
LPL Financial
California
-$23.1K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$365K
2
$323K
3
$133K
4
$66K
5
$65K
6
$59K
7
$53K
8
$40K
9
$35K
10
$29K
11
$24K
12
$21K
13
$20K
14
$19K
15
$19K
16
$19K
17
$17K
18
$13K
19
$12K
20
$12K
21
$4K
22
$3K
23
$2K
24
$1.71K
25
$1K